Conventional fractionated radiotherapy outcomes for young dogs with nephroblastoma of the spinal cord: 5 cases

Abstract

AbstractPublished radiotherapy results for spinal nephroblastomas in dogs are limited. In this retrospective longitudinal study (1/2007–1/2022), five dogs with a median age of 2.8 years received post‐operative 3D conformal, conventional fractionated radiotherapy (CFRT) with 2–4 fields (parallel‐opposed with or without two hinge‐angle fields), for an incompletely resected nephroblastoma. Clinical findings prior to surgery included one or more of the following: pelvic limb paresis (5), faecal incontinence (2), flaccid tail (1), non‐ambulatory (2) and deep pain loss (1). All masses were located between T11 and L3 and surgically removed via hemilaminectomy. Dogs received 45–50 Gray (Gy) in 18–20 fractions, and no dogs received chemotherapy post‐radiation. At analysis, all dogs were deceased, with none lost to follow‐up. The median overall survival (OS) from first treatment to death of any cause was 3.4 years (1234 days; 95% CI 68 days‐upper limit not reached; range: 68–3607 days). The median planning target volume was 51.3 cc, with a median PTV dose of 51.4 Gy and median D98 = 48.3 Gy. Late complications or recurrence was difficult to fully determine in this small dataset; however, some degree of ataxia persisted throughout life in all dogs. This study provides preliminary evidence that post‐operative radiotherapy may result in prolonged survival times dogs with spinal nephroblastomas.